Osteonecrosis Pipeline Review: H1 2018 - Therapeutics Development & Assessment, Companies Involved, and Drug Profiles Covered - ResearchAndMarkets.com
Jun. 11, 2018
DUBLIN--(BUSINESS WIRE)--Jun 11, 2018--The "Osteonecrosis - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.
This latest pipeline guide provides comprehensive information on the therapeutics under development for Osteonecrosis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Osteonecrosis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteonecrosis and features dormant and discontinued projects.
The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III, Phase II and Preclinical stages are 1, 1 and 3 respectively.
Companies MentionedBone Therapeutics SA Enzo Biochem Inc K-Stemcell Co Ltd
Key Topics CoveredIntroduction Report Coverage Osteonecrosis - Overview Osteonecrosis - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Osteonecrosis - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Osteonecrosis - Companies Involved in Therapeutics Development Osteonecrosis - Drug Profiles
For more information about this report visit https://www.researchandmarkets.com/research/w6zcdq/osteonecrosis?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180611005897/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Musculoskeletal Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 06/11/2018 12:50 PM/DISC: 06/11/2018 12:51 PM